LDLR and atherosclerosis: Statins reduce LDL cholesterol levels and prevent ASCVD by inhibiting 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and increasing the expression of low density lipoprotein receptor (LDLR) (Grundy et al., 2018).